As cancer drug shortages persist, ASCO official urges congressional action at hearing
Fierce Pharma
FEBRUARY 9, 2024
the American Society of Clinical Oncologists (ASCO) is again pushing Congress to act to end the crisis. | The oncology drug supply crisis has entered its second year, and doctors still face "impossible choices" without access to standard-of-care therapies, ASCO's chief medical officer, Dr.
Let's personalize your content